Nevada Tech Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nevada Tech Journal.

Press releases published on November 6, 2026

9 hours ago

The Coupon Chaser Launches Coupon Verification Technology That Tests Codes at Live Checkouts

Indeterminate EIN Presswire

23 minutes ago

Constellation Software Inc. Announces Results for the Third Quarter Ended September 30, 2026 and Declares Quarterly Dividend

Indeterminate GlobeNewswire

31 minutes ago

Parker Scheduled to Present at Robert W. Baird Global Industrial Conference on November 10 at 10:50 a.m. Central Time (11:50 a.m. Eastern Time)

Indeterminate GlobeNewswire

an hour ago

Surrozen to Present at Upcoming Healthcare Investor Conference

Indeterminate GlobeNewswire

an hour ago

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

an hour ago

Entera Announces Third Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

an hour ago

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

an hour ago

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

an hour ago

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

an hour ago

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2026

Indeterminate GlobeNewswire

1 hours ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

1 hours ago

IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

1 hours ago

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

1 hours ago

Nkarta to Host Webcast to Discuss Initial Clinical Data for NKX019 in Autoimmune Diseases at ACR Convergence 2026

Indeterminate GlobeNewswire

2 hours ago

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

2 hours ago

Identity and Biometric Authentication Technologies Provider BIO-key Hosts Q3 Investor Call Friday, November 13 at 10am ET

Indeterminate GlobeNewswire

2 hours ago

Wegweisende Therapie bei fortgeschrittener Herzinsuffizienz: Der wissenschaftliche Mitgründer von Repairon, Prof. Wolfram-Hubertus Zimmermann, erhält den „Galenus-von-Pergamon“-Preis 2026 für herausragende pharmakologische Grundlagenforschung

Indeterminate GlobeNewswire

2 hours ago

Une approche thérapeutique innovante pour le traitement de l’insuffisance cardiaque avancée : le professeur Wolfram-Hubertus Zimmermann, cofondateur scientifique de Repairon, reçoit le prix « Galenus-von-Pergamon » 2026 pour ses travaux exceptionnels d…

Indeterminate GlobeNewswire

2 hours ago

Hengrui Pharma and Braveheart Bio Present Data from 52-Week Open-Label Extension of Phase 2 Study of HRS/BHB-1893 in Obstructive Hypertrophic Cardiomyopathy at American Heart Association Scientific Sessions 2026

Indeterminate GlobeNewswire

3 hours ago

Tactfolio Inc. Launches AI-Compatible Platform for Building, Backtesting, and Automating Trading Strategies

Indeterminate GlobeNewswire